Seoul, South Korea

Hong Chul Yun

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Chul Yun. Retrieved from https://idiyas.com/inventor/hong-chul-yun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hong Chul Yun

Introduction

Hong Chul Yun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of compounds that can be utilized in the pharmaceutical industry. His work is characterized by a focus on innovative methods for synthesizing important chemical intermediates.

Latest Patents

Hong Chul Yun holds 1 patent. His patent involves a compound represented by a general formula (Ia) or (Ib) and a stereo-selective preparation method using a carbonyl reductase. This compound can be prepared by the reduction of substituted β-keto esters and serves as an intermediate in the preparation of β-lactam group antibiotics. This innovation has the potential to enhance the efficiency of antibiotic production.

Career Highlights

Hong Chul Yun is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work at this esteemed institution has allowed him to explore various aspects of chemical synthesis and its applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Joo Hwan Cha and Ye Sun Han. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Hong Chul Yun's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing pharmaceutical science. His work not only highlights his expertise but also underscores the importance of collaboration in driving innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…